Summary
- Current Price
- As of today, IOVA price is $4.09, up +2.76% on
- Current Price All-Time High
- IOVA price is currently -97.52% below its historical high of $165.00 set on
- Market Cap
- IOVA current market cap is $2B, up +74.72% over the past 365 days
- PE Ratio
- IOVA PE ratio is unknown
- Revenue
- IOVA current annual revenue is $263.50M, up +60.60% year-over-year
- Next Earnings
- The next earnings release for IOVA is on
Profile
| Metric | Value |
|---|---|
| Full Name | Iovance Biotherapeutics, Inc. |
| Ticker | NASDAQ: IOVA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | iovance.com |
| Employees | 838 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $4.09 | |
| Price, 1D Change | +2.76% | |
| $2B | ||
| - | ||
| - | ||
| 1.99 | ||
| $264M | ||
| Revenue, 1Y Change | +60.60% | |
| -$1.09 | ||
| EPS, 1Y Change | +14.78% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:100 | |
| Next Split | N/A | N/A |
| Last Ticker Change | LBIO | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.09 | ||
| EPS Estimate | N/A | -$0.54 |
| EPS Est. Change | N/A | +50.55% |
| $263.50M | ||
| Revenue Estimate | N/A | $359.68M |
| Revenue Est. Change | N/A | +36.50% |
| Current Price | $4.09 | |
| Price Target | - | $9.50 |
| Price Tgt. Change | - | +132.27% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.29 | -$1.28 | +0.47% | |
| -$1.08 | -$1.09 | -1.21% | |
| -$0.54 | N/A | +50.55% | |
| -$0.28 | N/A | +74.58% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $162.64M | $164.07M | +0.88% | |
| $258.36M | $263.50M | +1.99% | |
| $359.68M | N/A | +36.50% | |
| $534.26M | N/A | +102.75% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $4.09 | |
| $2.78 | ||
| SMA 200 vs Price | -31.96% | |
| $3.82 | ||
| SMA 50 vs Price | -6.72% | |
| 1.99 | ||
| $0.26 | ||
| 63.09 | ||
| 71.63% | ||
| 111.35% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $263.50M | ||
| -$1.09 | ||
| $54.38M | ||
| 20.64% | ||
| -$398.21M | ||
| -151.12% | ||
| -$390.98M | ||
| -148.38% | ||
| -$362.27M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 3.20 | ||
| 2.83 | ||
| - | ||
| 4 | ||
| 0.10 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 6.93 | ||
| 2.61 | ||
| -4.46 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $698.58M | ||
| $296.98M | ||
| $913.17M | ||
| $442.69M | ||
| $214.59M | ||
| $138.36M | ||
| $49.44M | ||
| $5.04M | ||
| $22.16M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $654.48M | ||
| $452.59M | ||
| $209.12M | ||
| $0.00 | ||
| $47.32M | ||
| $0.00 | ||
| -$2.07M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$302.41M | ||
| $47.50M | ||
| $300.77M | ||
| $33.84M | ||
| -$336.24M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Chardan Capital | → | |
| UBS | → | |
| Citizens | → | |
| Citizens | → | |
| Barclays | → | |
| Barclays | → | |
| Barclays | → | |
| Chardan Capital | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with IOVA
FAQ
What is the ticker symbol for Iovance Biotherapeutics, Inc.?
The ticker symbol for Iovance Biotherapeutics, Inc. is NASDAQ:IOVA
Does Iovance Biotherapeutics, Inc. pay dividends?
No, Iovance Biotherapeutics, Inc. does not pay dividends
What sector is Iovance Biotherapeutics, Inc. in?
Iovance Biotherapeutics, Inc. is in the Healthcare sector
What industry is Iovance Biotherapeutics, Inc. in?
Iovance Biotherapeutics, Inc. is in the Biotechnology industry
What country is Iovance Biotherapeutics, Inc. based in?
Iovance Biotherapeutics, Inc. is headquartered in United States
When did Iovance Biotherapeutics, Inc. go public?
Iovance Biotherapeutics, Inc. initial public offering (IPO) was on October 15, 2010
Is Iovance Biotherapeutics, Inc. in the S&P 500?
No, Iovance Biotherapeutics, Inc. is not included in the S&P 500 index
Is Iovance Biotherapeutics, Inc. in the NASDAQ 100?
No, Iovance Biotherapeutics, Inc. is not included in the NASDAQ 100 index
Is Iovance Biotherapeutics, Inc. in the Dow Jones?
No, Iovance Biotherapeutics, Inc. is not included in the Dow Jones index
When was Iovance Biotherapeutics, Inc. last earnings report?
Iovance Biotherapeutics, Inc.'s most recent earnings report was on February 24, 2026
When does Iovance Biotherapeutics, Inc. report earnings?
The next expected earnings date for Iovance Biotherapeutics, Inc. is May 7, 2026
Data Sources & References
- IOVA Official Website www.iovance.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1425205/000110465926018899/0001104659-26-018899-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1425205/000110465926018899/0001104659-26-018899-index.htm
- IOVA Profile on Yahoo Finance finance.yahoo.com/quote/IOVA
- IOVA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/iova